Owkin becomes ‘unicorn’ with $180m investment from Sanofi and four new collaborative projects

Latest Posts

VLA2001 becomes the first COVID-19 vaccine to receive a standard marketing authorization in Europe

28 June 2022

Valneva receives marketing authorization in Europe for inactivated whole-virus COVID-19 vaccine VLA2001 Valneva , a specialty vaccine company, today announced... View Article

Valneva receives marketing authorization in Europe for inactivated whole-virus COVID-19 vaccine VLA2001

24 June 2022

VLA2001 becomes the first COVID-19 vaccine to receive a standard marketing authorization in Europe Valneva, a specialty vaccine company, today... View Article

Valneva announces settlement agreement with the UK Government

16 June 2022

Valneva, a specialty vaccine company, today announced that it has entered into a settlement agreement with the Government of the... View Article

« Previous 1 … 15 16 17 18 19 … 160 Next »